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Canonical-type transient receptor potential cation channel 3 (TRPC3), an ex-
tracellular Ca2þ entry channel in the t-tubule and plasma membrane, is re-
quired for full-gain of skeletal EC coupling. The present study examined ad-
ditional role(s) for TRPC3 in skeletal muscle other than mediation of EC
coupling. We created a stable myoblast line (MDG/TRPC3 KD myoblast)
with reduced TRPC3 expression by knock-down of TRPC3 using retrovi-
rus-delivered small interference RNAs in a1SDHPR-null muscular dysgenic
myoblasts to eliminate any DHPR-mediated EC coupling-related events. Un-
like a1SDHPR-null muscular dysgenic myoblasts, MDG/TRPC3 KD myo-
blasts exhibited dramatic changes in cellular morphology (e.g., unusual ex-
pansion of both cell volume and the plasma membrane, and multi-nuclei)
and increased Ca2þ content in both the endoplasmic reticulum and cytoplasm
of resting myoblasts. Moreover, these myoblasts failed to differentiate into
myotubes. Therefore, TRPC3 in skeletal myoblasts is essential for mainte-
nance of skeletal muscle.
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TRPC channels have been identified as components of Ca2þ signaling path-
ways that promote maladaptive growth of the myocardium. Transgenic mice
over-expressing TRPC3 or 6 exhibited an increased propensity towards hyper-
trophic progression in response to pressure overload, in part through a Ca2þ-
dependent calcineurin-NFAT signaling pathway. Moreover, different TRPC
subunits are known to be up-regulated in heart failure and in hypertrophic
hearts after pressure overload. In this study we inhibited TRPC channel func-
tion with dominant negative (dn) TRPC mutants and examined the ensuing ef-
fect on cardiac hypertrophy and Ca2þ influx dynamics. One of these mutants
comprises an N-terminal TRPC4 fragment that we used to generate cardiac re-
stricted transgenic mice. Intracellular Ca2þ signals were measured in adult car-
diac myocytes of wildtype (WT) and dn-TRPC4 mice that underwent TAC
(transverse aortic banding) or a sham procedure. Isolated myocytes maintained
in Ca2þ-free buffer were store-depleted with CPA while being treated with
Ang II, followed by perfusion with Ca2þ containing buffer to analyze Ca2þ
influx with Fura-2 fluorescence. WT myocytes showed essentially no Ca2þ en-
try, however, hypertrophic myocytes that underwent TAC showed abundant
Ca2þ influx. SKF96365 inhibited this Ca2þ influx, suggesting a role for
TRPC channels. Indeed, isolated myocytes from dnTRPC4 transgenic mice
subjected to TAC lacked this Ca2þ influx, confirming that TRPC channels me-
diate this previously unrecognized influx activity associated with hypertrophy
in cardiac myocytes. Interestingly, Ca2þ transients from myocytes of dn-
TRPC4 mice showed increased peak amplitudes, which might indicate an in-
creased cardiac contractility and cardiac performance when dn-TRPC4 is ex-
pressed. More importantly, dnTRPC4 mice showed significant attenuation of
cardiac hypertrophy following TAC stimulation. These data show that inhibi-
tion of TRPC channels exerts ameliorative effects on the development of car-
diac hypertrophy by decreasing Ca2þ signals that likely regulate pro-hypertro-
phic pathways.
1785-Pos
Analysis of the Role of TRPC3 in Ca2þ Signaling of RBL-2H3 Mast Cells
Hannes Schleifer1, Michael Poteser1, Isabella Derler2,
Christian Oliver Kappe1, Christoph Romanin2, Klaus Groschner1.
1University of Graz, Graz, Austria, 2Johannes Kepler University Linz,
Linz, Austria.
Direct or indirect involvement of TRPC channels in store-operated Ca2þ entry
(SOCE) has repeatedly been proposed. In this study, we explored the role of
TRPC3 in SOCE-associated Ca2þ signaling of RBL-2H3 mast cells by employ-
ing both genetic and pharmacological strategies. Mast cells overexpressing
a fluorescence-tagged, functional TRPC3 fusion protein displayed enhanced
Ca2þ entry in a classical thapsigargin-induced store depletion/calcium re-entry
protocol. A well-characterized dominant-negative, n-terminal fragment of
TRPC3 (aa 1-302) reduced SOCE significantly down to basal entry. A similar
extent of inhibition was observed with a dominant negative mutant of Orai1
(E106Q). Two pore mutants of TRPC3 (E616K and E630Q), which represent
a non-functional, dominant negative protein and a protein with distinctly al-
tered cation permeability, respectively, failed to affect SOCE in RBL-2H3
cells. The pyrazol compound Pyr3 (ethyl-1-(4-(2,3,3-trichloroacrylamide)-
phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate), which was recently
proposed as a selective inhibitor of TRPC3 channels, effectively suppressed
SOCE in wild-type controls as well as TRPC3 over-expressing cells. Our re-sults argue against a role of TRPC3 as part of the store-operated Ca2þ perme-
ation pathway in RBL-2H3 cells and point towards an indirect link between
TRPC3 and SOCE.
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Myoblasts migration is a key step in myogenesis. It allows myoblasts alignment
and their fusion into myotubes. The process has been shown to involve m- or
m-calpains, two calcium-dependent cysteine proteases. Fluorometric measure-
ments of calpain activity in cultured cells showed a peak at the beginning of
the differentiation process. We also observed a concomitant and transient in-
crease of the influx of Ca2þ and of the expression of TRPC1 protein. After repres-
sion of TRPC1 in myoblasts by siRNA and shRNA, this transient influx of
calcium was significantly reduced and the concomitant peak of calpain activity
was abolished. Interestingly, myoblasts fusion into myotubes was significantly
slowed down, due to a reduced speed of cell migration. Accordingly, migration
of control myoblasts was inhibited by 2 to 5 mM GsMT4 toxin, an inhibitor of
TRP channels or by 50mM Z-Leu-Leu, an inhibitor of calpain. These effects were
not observed in TRPC1 knocked down cells. Moreover, TRPC1 knocked down
myoblasts also accumulated of myristoylated alanine-rich C-kinase substrate
(MARCKS), an actin-binding protein, substrate of calpain. We therefore suggest
that an entry of calcium through TRPC1 channels induces a transient activation
of calpain, a subsequent proteolysis of MARCKS, allowing in its turn, myoblasts
migration and fusion. The role of TRPC1 in muscle regeneration, a process in-
volving myoblasts migration and differentiation, is under study.To further char-
acterize the role of TRPC1 in muscle development, we compared morphological
and mechanical parameters of muscles from TRPC1þ/þ and TRPC1-/- mice. We
observed that muscles from TRPC1-/- mice display a smaller fibre cross-sectional
area and generate less force per cross section area. They do not present other ma-
jor signs of myopathy but were more sensitive to muscle fatigue.
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Autosomal dominant polycystic kidney disease (ADPKD) is one of the most
common genetic diseases in human and is caused by mutations in PKD1 and
TRPP2 proteins. PKD1 (also known as polycystin-1 or PC1) is a large integral
membrane protein with 11 putative transmembrane regions, a large extracellu-
lar N terminus and a short intracellular C terminus. PKD1 is generally thought
to function as a cell surface receptor that couples extracellular stimuli to intra-
cellular signaling. TRPP2 (also known as polycystin-2, PKD2 or PC2) is
a member of the transient receptor potential (TRP) channel family. It has 6 pu-
tative transmembrane segments and a pore-forming loop and forms a Ca2þ-
permeable nonselective cation channel. How mutations in PKD1 and TRPP2
lead to ADPKD is unclear but these two proteins likely share some common
functions since mutations in them produce similar pathological manifestations.
These two proteins associate physically through their C-termini and form func-
tional complexes. However, the subunit composition of this complex and the
molecular mechanism of its assembly are unknown. By combining biochemis-
try, X-ray crystallography, and a single molecule imaging method to determine
the subunit composition of proteins in the plasma membrane of live cells, we
find that this complex contains 3 TRPP2 and 1 PKD1. A C-terminal coiled
coil domain of TRPP2 is critical for the assembly of this complex. This coiled
coil domain forms a homotrimer and binds to a single coiled coil domain in the
C-terminus of PKD1. Mutations that disrupt this coiled coil trimer abolish the
assembly of both full-length TRPP2 homotirmer and the TRPP2/PKD1 hetero-
meric complex, and diminish the surface expression of both proteins. These
finding have significant implications for the assembly, regulation and function
of the TRPP2/PKD1 complex, and for the pathogenic mechanism of some
ADPKD-producing mutations.
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